Assessment of voluntary HIV screening for asylum seekers in two Swiss cantons.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
11 02 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 14 6 2019
Statut: epublish

Résumé

To evaluate the feasibility of HIV screening, offered to newly arrived asylum seekers in the Swiss cantons of Valais (VS) and Vaud (VD) in order to meet the national and international standards for early detection and effective treatment of HIV infections. HIV screening was offered free of charge to every asylum seeker who arrived from June 2015 to November 2016 in VS, and from June to October 2016 in VD. Pregnant women and children <16 were excluded. Written consent was required in VS through multi-language forms, whereas VD required oral consent obtained with the help of interpreters. 807 asylum seekers were offered HIV testing (VS 451, VD 356). Their mean age was 27.6 years, 61.2% were male, 67.4% were single, 60.8% arrived from sub-Saharan Africa. The overall proportion that accepted HIV screening was 72.2% (VS 63.2%, VD 83.7%). Prevalence of HIV infection was 0.87% (two newly and five previously diagnosed persons). Multivariable analysis found that a higher proportion accepted HIV testing among asylum seekers originating from sub-Saharan Africa, men, and those arriving in VD. the acceptance of HIV screening among asylum seekers was high and appeared to respond to a real demand among this vulnerable population, particularly among those coming from high endemic regions. It may help guaranteeing an equitable access to the local health care system. Ways to reach a high testing rate should still be explored, taking available and necessary resources into account.

Identifiants

pubmed: 30769343
doi: 10.4414/smw.2019.20020
pii: Swiss Med Wkly. 2019;149:w20020
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20020

Auteurs

Laure Cochand (L)

School of medicine, University of Lausanne, Switzerland.

Eric Masserey (E)

Public Health Service, Canton of Vaud, Lausanne, Switzerland.

Patrick Bodenmann (P)

Vulnerable Population Centre, Department of Ambulatory Care and Community Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Nicolas Troillet (N)

Department of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland / Departments of Infectious Diseases and of Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH